CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 101 enrolled
Drug / intervention
UroLift System Proceduredevice
Likely dose
UroLift System minimally invasive urethral lift procedureAI-extracted
Key inclusion· 5
  • ✓Male gender
  • ✓Symptomatic benign prostatic hyperplasia (BPH)
  • ✓Age ≥50 years
  • ✓Prostate volume ≤100 cc on ultrasound
Key exclusion· 20
  • ✕Obstructive or protruding median lobe of the prostate
  • ✕Previous BPH surgical procedure
  • ✕Previous pelvic surgery
  • ✕Retention volume >1500 mL

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03194737
NCT03194737N/ACompleted
CompareCT.gov

Prostatic Urethral Lift in Subject With Acute Urinary Retention

NeoTract, Inc.·interventional·Posted Jun 21, 2017·Updated Jul 16, 2021

In Brief

A clinical study evaluating UroLift System Procedure for Acute Urinary Retention and Benign Prostatic Hyperplasia. Completed, enrolled 101 participants across 6 sites.

Detailed Summary

Assess feasibility and safety of the Prostatic Urethra Lift (PUL) procedure in patients with acute urinary retention secondary to benign prostatic hyperplasia (BPH).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAcute Urinary Retention, Benign Prostatic Hyperplasia
CountriesUnited Kingdom
Collaborators--

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedJun 21, 2017
Enrollment StartMar 24, 2018
Primary CompletionJan 21, 2019
Study CompletionMar 3, 2020
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 9.0 years ago

Interventions

UroLift System Proceduredevice

Minimally invasive procedure in patients with acute urinary retention secondary to BPH.